DIPG-81. PHASE IB CLINICAL TRIAL ASSESSING SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF ALOCELYVIR (ALLOGENEIC MESENCHYMAL CELLS + ONCOLYTIC ADENOVIRUS) COMBINED WITH RADIOTHERAPY IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

DIPG-81. PHASE IB CLINICAL TRIAL ASSESSING SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF ALOCELYVIR (ALLOGENEIC MESENCHYMAL CELLS + ONCOLYTIC ADENOVIRUS) COMBINED WITH RADIOTHERAPY IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

Saved in:
Bibliographic Details
Published in:Neuro-oncology (Charlottesville, Va.) Vol. 26; no. Suppl 4
Main Authors: Lassaletta, Alvaro, Vazquez-Gomez, Felisa, Rubio, Alba, Moreno-Carrasco, Jose Luis, Sansegundo, Carmen Gonzalez, Gonzalez-Murillo, Africa, Horcajo-Morera, Beatriz, Bautista, Francisco, Garcia-Aguilera, Gonzalo, Castillo, Ana, Solís, Ines, Borrego, Pedro, Llort, Anna, Castellano, Serafin, Perez-Somarriba, Marta, Garcia-Ariza, Miguel, Galera, Ana, Melwani, Kishore, Ippolito, Hyaissa, Rivero, Belen, Melen, Gustavo, Garcia-Castro, Javier, Ramirez, Manuel
Format: Journal Article
Language:English
Published: US Oxford University Press 18-06-2024
Subjects:
Final category: Diffuse Midline Glioma, Diffuse Intrinsic Pontine Glioma
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1522-8517
1523-5866
DOI:10.1093/neuonc/noae064.134